News
Important Only
Brazil's BTG Pactual posts Q2 earnings beat as revenue jumps
SAO PAULO, Aug 12 (Reuters) - Brazilian lender BTG Pactual BPAC3.SA reported better-than-expected second-quarter results on Tuesday, with revenues across all business segments rising by double-digit percentages on a yearly basis.WHY IT'S IMPORTANTBTG Pactual is Latin America's largest invest...Reuters
Tue, Aug 12
Acumen Pharmaceuticals Q2 net loss widens
OverviewAcumen Q2 net loss widens to $41.0 mln, driven by increased R&D expensesCash reserves of $166.2 mln expected to support operations into early 2027OutlookCash reserves expected to support operations into early 2027Result DriversSCREENING INNOVATIONS - Co implemented a two-step screening p...Reuters
Tue, Aug 12
EU cannot give timeline for US tariff order on cars or joint statement
BRUSSELS, Aug 12 (Reuters) - The European Union was unable to say when a joint statement on tariffs with the United States will be ready nor when it expects the White House to issue an executive order on European car import duties, a European Commission spokesperson said on Tuesday. "It is an ag...Reuters
Tue, Aug 12
Morning News Call - U.S., August 12
To access a PDF version of this newsletter, please click hereYou can read Morning News Call -- US via TOPNEWS U.S. Companies page.If you would like to receive this newsletter through your email, please register at:https://solutions.lseg.com/MorningNewsCallEN-subscription-pageFor Morning News Call Ca...Reuters
Tue, Aug 12
Amphastar Pharmaceuticals Enteres License Agreement With Nanjing Anji Biotechnology
Aug 12 (Reuters) - Amphastar Pharmaceuticals Inc AMPH.O:AMPHASTAR PHARMACEUTICALS INC - ON AUGUST 8, ENTERED LICENSE AGREEMENT WITH NANJING ANJI BIOTECHNOLOGY - SEC FILINGAMPHASTAR PHARMACEUTICALS INC - TO PAY UP TO $267 MILLION IN MILESTONE PAYMENTS - SEC FILINGAMPHASTAR PHARMACEUTICALS INC - PAY...Reuters
Tue, Aug 12
Circle Reports Second Quarter 2025 Results
Aug 12 (Reuters) - Circle Internet Group Inc CRCL.N:CIRCLE REPORTS SECOND QUARTER 2025 RESULTS: TOTAL REVENUE AND RESERVE INCOME GREW 53% YEAR-OVER-YEAR TO $658 MILLION IN Q2OUTLOOK FY 2025 OTHER REVENUE $75 MILLION-$85MLN: PAID $424 MILLION FOR STOCK-BASED COMPENSATION RELATED TO VESTING CONDITIONS...Reuters
Tue, Aug 12
Applied Therapeutics Says Unaudited Estimate Of Total Stockholders’ Equity As Of June 30 Is About $17.4 Mln
Aug 12 (Reuters) - Applied Therapeutics Inc APLT.O:APPLIED THERAPEUTICS INC - PRELIM UNAUDITED ESTIMATE OF TOTAL STOCKHOLDERS’ EQUITY AS OF JUNE 30, 2025 IS ABOUT$17.4 MILLION - SEC FILINGReuters
Tue, Aug 12
Cineplex's Q2 revenue rises 30.5% on higher in-theatre demand
OverviewCineplex Q2 2025 rev rises 30.5% yr/yr, driven by premium experiencesAdjusted EBITDA for Q2 2025 jumps 80.1% yr/yr, reflecting strong operational performanceCompany reports net loss of C$2.2 mln, significantly reduced from prior yearOutlookCineplex anticipates continued demand for theatrical...Reuters
Tue, Aug 12
Digital therapeutics platform DarioHealth Q2 revenue falls steeper-than-expected 14%
OverviewDarioHealth Q2 2025 revenue fell 14% yr/yr to $5.4 mln, missing expectationsOperating loss for Q2 narrowed by 43% yr/yr due to operational efficienciesCo secured $5 mln new CARR, with $53 mln pipeline of opportunitiesOutlookDario expects cashflow breakeven by end of 2026 to early 2027Company...Reuters
Tue, Aug 12
Sotherly Hotels Q2 revenue falls
OverviewSotherly Hotels Q2 revenue falls 3.7% yr/yr, missing analyst expectations, per LSEG dataCo plans sale of parking garage to enhance liquidityOutlookCompany revises 2025 revenue guidance to $185.2 mln to $188.2 mlnSotherly expects 2025 net loss between $1.2 mln and $0.6 mlnSotherly sees 2025 F...Reuters
Tue, Aug 12
Rapid Micro Biosystems Q2 revenue up 10%, beats estimates
OverviewRapid Micro Biosystems Q2 revenue grows 10%, beating analyst expectationsNet loss for Q2 was $11.9 mln, missing analyst estimatesCo enters $45 mln loan facility to strengthen financial positionOutlookCompany reaffirms full-year 2025 revenue guidance of at least $32 mlnCompany expects new loa...Reuters
Tue, Aug 12
